This article only represents the author's own views.
It’s a new week, with yet more signs that the China-U.S. IPO pipeline is slowly creaking back to life. This time it’s a relatively small IPO by a medical device maker named Meihua International Medical Technologies Co. Ltd. that’s making headlines with the company’s latest filing for a plan to raise a modest $57 million.
At the same time, two new listings we wrote about last week have also moved forward. The first saw drug maker LianBio’s (LIAN.US) shares fizzle in their trading debut, falling 14% on their first trading day, as it became the first major New York listing by a Chinese company since a halt in July. The second saw hotel operator Atour Lifestyle Holdings Ltd. (ATAT.US) file an updated prospectus for its plan to raise about $350 million.